CD4 and neoplasm: According to D’Amico, DKK1 activates Myeloid-derived suppressor cell (MDSC), a suppressor of tumor immunology, to indirectly reduce accumulation of CD4+ and CD8+ TILs in Lewis lung carcinoma, pancreatic cancer as well as B16 melanoma [22].